Researchers at the University of Pennsylvania School of Medicine have found an association between the genetics of donor-recipient matches in kidney transplants and complications during the first week after transplantation.
Get the full story...
Withdrawing certain immunosuppressive drugs following kidney transplantation prolongs survival and saves money compared with keeping patients on these medications for life, according to a study appearing in the September 2008 issue of the Journal of the American Society Nephrology (JASN).
Get the full story...
A new study documents malformations seen in an infant born to a kidney transplant recipient who had taken mycophenolate mofetil (MMF), a widely used immunosuppressant available commercially as Cellcept®.
Get the full story...
Biocon Limited, India's premier biotechnology company has announced the launch of its new Nephrology Division and a comprehensive portfolio of renal therapy products today. The products were launched by Smt. Sudha Murthy at a press conference.
Read the full story
A new study on liver retransplantation (re-LT) over a 15 year period at a clinic in Germany found that indications for the surgery had changed and there were fewer rejections, complications, and recurrence of disease during that time. The positive trend may be due to improvements in intensive care management and immunosuppressants, along with early decisions about when to retransplant despite the shortage of quality donor organs.
Read the full story
